How to choose contingency management software: the evidence, incentive limits to plan around, state Medicaid programs, budgeting, and the questions to ask every vendor.
Contingency management (CM) has moved from a research protocol to a mainstream treatment option. Federal grant rules loosened in 2025, several state Medicaid programs now pay for it, and addiction medicine guidelines name it as a first-line treatment for stimulant use disorder. The hard part for most programs is no longer whether to offer CM. It is how to run it reliably, legally, and at a cost that makes sense.
This guide walks through what CM is, the evidence behind it, the rules that shape incentive budgets, the software features that matter, and the questions to ask before you sign a contract.
Contingency management is a behavioral treatment that gives patients small, immediate rewards when they meet a specific, verifiable goal. The classic target is a negative drug test, but programs also reward session attendance, medication adherence, and other treatment milestones.
Rewards are usually gift cards, vouchers, or prize draws. A typical program, as described in an APA Monitor overview of CM, involves twice-weekly clinic visits for testing over 12 to 24 weeks.
CM works because it makes the payoff for recovery immediate and concrete. Most of the benefits of not using a substance arrive slowly. A reward delivered the same day as a negative test closes that gap.
CM is one of the most studied interventions in addiction treatment. The APA Monitor reports that CM has been tested in more than 100 studies, and at least seven systematic reviews and meta-analyses rate it as the most effective available intervention for stimulant use disorder. The same article notes that 2024 guidelines from the American Society of Addiction Medicine and the American Academy of Addiction Psychiatry named CM the frontline treatment for stimulant use disorder.
The Department of Veterans Affairs has run CM at scale since 2011. A national evaluation in Drug and Alcohol Dependence found that 94 VA stations had offered CM to 2,060 patients, and that 91.1% of urine samples tested negative for the target substance on average. The authors concluded that outcomes were comparable to controlled trials.
The APA Monitor also cites a study of nearly 3,000 VA patients with stimulant use disorder in which those who received CM were 41% less likely to die within a year.
CM is not only for abstinence. A 2021 meta-analysis in the Journal of Substance Abuse Treatment pooled 10 studies with 1,841 participants and found that rewarding attendance alone had a moderate effect on treatment attendance (d = 0.47). More frequent rewards were linked to larger effects. For outpatient programs that struggle with dropout, this is a practical entry point.
Larger rewards tend to work better. Pew summarizes research showing that rewards in the range of $400 to $560 reduce stimulant use, with larger reductions at higher amounts. That is why the incentive caps below matter so much.
This section is a summary for planning purposes, not legal advice. Review your program design with healthcare counsel.
The figure most people mean by "the $75 cap" comes from the HHS Office of Inspector General. Under federal beneficiary inducement rules, OIG treats non-cash items worth no more than $15 each and $75 in aggregate per patient per year as nominal, according to a NACHC issue brief on patient incentive programs. The brief notes that store-based gift cards within those limits are well suited to rewarding healthy behaviors. As of this writing, we did not find any change to these thresholds in 2025 or 2026.
Programs that want to exceed nominal value need another basis, such as a regulatory exception, a safe harbor, an OIG advisory opinion, or a state program with its own approval.
In 2022, OIG issued a favorable advisory opinion on a digital CM program that capped incentives at $200 per month and $599 per year. OIG said it would not impose sanctions, citing safeguards such as a protocol-driven design, incentives that phase out over time, and payment cards that block purchases at bars, liquor stores, and casinos. Advisory opinions only protect the party that requested them, but they show what OIG considers lower-risk.
For programs funded by SAMHSA grants, the old limit was $75 per patient per year. In January 2025, SAMHSA raised it to $750 per patient per year, as reported by the American Academy of Addiction Psychiatry. The guidance has no set limit on each individual incentive, does not allow cash, requires evidence-based CM models, and requires that all participants have an equal chance to earn the same amounts. The APA Monitor notes that states can use State Opioid Response and Tribal Opioid Response grants for these payments.
California, Washington, and Montana have received federal approval through Section 1115 waivers to use Medicaid funding for CM, according to the APA Monitor. Vermont, Connecticut, and Michigan fund CM with opioid settlement dollars.
California's Recovery Incentives Program is one of the best-known examples. Per the DHCS program page, it serves Medi-Cal members with stimulant use disorder in 23 participating Drug Medi-Cal Organized Delivery System counties. The DHCS FAQ describes a 24-week protocol, a maximum of $599 per calendar year, and an extension through at least the end of the CalAIM 1115 demonstration on December 31, 2026. The program has reached nearly 10,000 patients at 111 sites, according to the APA Monitor.
Your budget has two parts: the rewards themselves and the cost of running the program.
Rewards. Start with your funding source, because it sets the ceiling. A program operating within OIG nominal value guidance works with roughly $75 per patient per year, or about $6 per month. A SAMHSA-funded program can go up to $750. A state Medicaid program follows the state's schedule, such as California's $599.
Operations. Count staff time for verifying behaviors, logging results, buying and sending gift cards, reconciling balances, and producing reports. This is where manual processes add up. Gift card purchasing and delivery alone can take significant staff time.
A practical approach. Consider starting with a modest annual limit, rewarding attendance and engagement first, and expanding to abstinence-based rewards once workflows are stable. Use your first 60 to 90 days of data to decide where additional dollars would have the most effect.
Use this list when you evaluate platforms.
Verity for Patients is built for outpatient behavioral health and SUD organizations, including clinics, CCBHCs, IOP and PHP programs, OTPs, and youth programs. Its digital contingency management includes incentive caps, eligibility rules, and audit trails. Patients earn points, streaks, and quests through a gamified app and redeem them in a prize shop for gift cards. Verity handles prize procurement and delivery.
Setup takes about an hour, and programs can go live in seven days. Verity supports HIPAA and 42 CFR Part 2 and signs a BAA and QSOA. Measurement-based care with the PHQ-9, GAD-7, and 500+ assessments is included at no extra cost, and Verity integrates with behavioral health EHRs via API or SFTP. You can read results from programs like a Massachusetts CCBHC with 90% patient retention in our case studies, or contact us to talk through your CM design.
Contingency management software helps behavioral health programs run CM by tracking target behaviors, issuing rewards, enforcing incentive caps, and keeping an audit trail. Many platforms also handle gift card delivery and integrate with the EHR.
The $75 figure usually refers to OIG guidance that treats non-cash items worth up to $15 each and $75 per patient per year as nominal value. SAMHSA's old $75 grant limit was raised to $750 per patient per year in January 2025. State Medicaid programs set their own limits.
California's Recovery Incentives Program allows up to $599 per calendar year in gift card incentives for eligible Medi-Cal members with stimulant use disorder. The program uses a 24-week protocol.
Yes. A 2021 meta-analysis found that rewarding attendance alone had a moderate effect on treatment attendance, with larger effects when rewards were more frequent.
Look for automatic incentive caps, eligibility rules, audit trails, 42 CFR Part 2 compliance, EHR integration, non-cash reward delivery, and reporting on participation and spend.
It depends on your protocol and software. With Verity, setup takes about one hour, and programs can go live in seven days.